{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:16:48Z","timestamp":1765480608883,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"DOI":"10.7759\/cureus.98983","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:11:21Z","timestamp":1765480281000},"source":"Crossref","is-referenced-by-count":0,"title":["Incomplete Vogt-Koyanagi-Harada Syndrome Presenting With Sunset Glow Fundus, Vitiligo, Preserved Vision, and Incidental CA 19-9 Elevation"],"prefix":"10.7759","author":[{"given":"Nicolas","family":"Nicolaou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antigoni","family":"Koukkoulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loukiana","family":"Tsierkezou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133632","article-title":"Treatment and prognosis of Vogt-Koyanagi-Harada disease: real-life experience in long-term follow-up","volume":"11","author":"Accorinti M","year":"2022","unstructured":"Accorinti M, Saturno MC, Iannetti L, Manni P, Mastromarino D, Pirraglia MP. Treatment and prognosis of Vogt-Koyanagi-Harada disease: real-life experience in long-term follow-up. J Clin Med. 2022, 11:10.3390\/jcm11133632","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78209","article-title":"A case of Vogt-Koyanagi-Harada disease: diagnosis based on the presence of vitiligo and sunset glow fundus without ocular symptoms","volume":"17","author":"Tsutsui H","year":"2025","unstructured":"Tsutsui H, Fukuda K, Nakajima I, Yamashiro K. A case of Vogt-Koyanagi-Harada disease: diagnosis based on the presence of vitiligo and sunset glow fundus without ocular symptoms. Cureus. 2025, 17:10.7759\/cureus.78209","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2185_23","article-title":"VKH disease in the elderly: variations in clinical course as compared to VKH disease in adults","volume":"72","author":"Kaza H","year":"2024","unstructured":"Kaza H, Cherukuri N, Tyagi M, Basu S, Pappuru RR, Murthy S. VKH disease in the elderly: variations in clinical course as compared to VKH disease in adults. Indian J Ophthalmol. 2024, 72:580-3. 10.4103\/IJO.IJO_2185_23","journal-title":"Indian J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/eop.12.63","article-title":"Vogt-Koyanagi-Harada disease","volume":"7","author":"Attia S","year":"2012","unstructured":"Attia S, Khochtali S, Kahloun R, Zaouali S, Khairallah M. Vogt-Koyanagi-Harada disease. Expert Rev Ophthalmol. 2012, 7:565-85. 10.1586\/eop.12.63","journal-title":"Expert Rev Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.03.036","article-title":"Classification criteria for Vogt-Koyanagi-Harada disease","volume":"228","year":"2021","unstructured":"Classification criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2021, 228.205-11. 10.1016\/j.ajo.2021.03.036","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.848906","article-title":"Complete Vogt-Koyanagi-Harada disease and Holmes-Adie syndrome: case report","volume":"22","author":"Leon MG","year":"2014","unstructured":"Leon MG, Herrera-Jimenez IP, Gonz\u00e1lez-Madrigal PM. Complete Vogt-Koyanagi-Harada disease and Holmes-Adie syndrome: case report. Ocul Immunol Inflamm. 2014, 22:336-40. 10.3109\/09273948.2013.848906","journal-title":"Ocul Immunol Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000505","article-title":"Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma","volume":"28","author":"Diamantopoulos PT","year":"2018","unstructured":"Diamantopoulos PT, Stoungioti S, Anastasopoulou A, Papaxoinis G, Gogas H. Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma. Melanoma Res. 2018, 28:648-51. 10.1097\/CMR.0000000000000505","journal-title":"Melanoma Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-025-00484-8","article-title":"Immune checkpoint inhibitor-associated Vogt-Koyanagi-Harada-like syndrome: a descriptive systematic review","volume":"15","author":"Zhang HA","year":"2025","unstructured":"Zhang HA, Yuan AT, Chiasson N, Wu KY, Kalevar A. Immune checkpoint inhibitor-associated Vogt-Koyanagi-Harada-like syndrome: a descriptive systematic review. J Ophthalmic Inflamm Infect. 2025, 15:10.1186\/s12348-025-00484-8","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061012","article-title":"Vogt-Koyanagi-Harada disease exacerbation associated with COVID-19 vaccine","volume":"11","author":"De Domingo B","year":"2022","unstructured":"De Domingo B, L\u00f3pez M, Lopez-Valladares M, Ortegon-Aguilar E, Sope\u00f1a-Perez-Arg\u00fcelles B, Gonzalez F. Vogt-Koyanagi-Harada disease exacerbation associated with COVID-19 vaccine. Cells. 2022, 11:10.3390\/cells11061012","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1373827","article-title":"Induction of Vogt-Koyanagi-Harada disease by interferon-alpha and ribavirin treatment in patients with hepatitis C: a case report and review of the literature","volume":"27","author":"Duan J","year":"2019","unstructured":"Duan J, Wang Y, Liu D, Ma J. Induction of Vogt-Koyanagi-Harada disease by interferon-alpha and ribavirin treatment in patients with hepatitis C: a case report and review of the literature. Ocul Immunol Inflamm. 2019, 27:229-34. 10.1080\/09273948.2017.1373827","journal-title":"Ocul Immunol Inflamm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1483520","article-title":"Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination","volume":"27","author":"Sood AB","year":"2019","unstructured":"Sood AB, O'Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm. 2019, 27:524-7. 10.1080\/09273948.2018.1483520","journal-title":"Ocul Immunol Inflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v26i2.14","article-title":"Association of Vogt Koyanagi Harada syndrome and seronegative rheumatoid arthritis","volume":"26","author":"Aydin T","year":"2016","unstructured":"Aydin T, Taspinar O, Guneser M, Keskin Y. Association of Vogt Koyanagi Harada syndrome and seronegative rheumatoid arthritis. Ethiop J Health Sci. 2016, 26:193-6. 10.4314\/ejhs.v26i2.14","journal-title":"Ethiop J Health Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0715","article-title":"Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome","volume":"47","author":"Suzuki H","year":"2008","unstructured":"Suzuki H, Isaka M, Suzuki S. Type 1 diabetes mellitus associated with Graves' disease and Vogt-Koyanagi-Harada syndrome. Intern Med. 2008, 47:1241-4. 10.2169\/internalmedicine.47.0715","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0454","article-title":"Vogt-Koyanagi-Harada syndrome associated with psoriasis and autoimmune thyroid disease","volume":"88","author":"Kluger N","year":"2008","unstructured":"Kluger N, Mura F, Guillot B, Bessis D. Vogt-Koyanagi-Harada syndrome associated with psoriasis and autoimmune thyroid disease. Acta Derm Venereol. 2008, 88:397-8. 10.2340\/00015555-0454","journal-title":"Acta Derm Venereol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65720-8","article-title":"Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases","volume":"10","author":"Kim S","year":"2020","unstructured":"Kim S, Park BK, Seo JH, et al.. Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases. Sci Rep. 2020, 10:10.1038\/s41598-020-65720-8","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439227-incomplete-vogt-koyanagi-harada-syndrome-presenting-with-sunset-glow-fundus-vitiligo-preserved-vision-and-incidental-ca-19-9-elevation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:11:21Z","timestamp":1765480281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439227-incomplete-vogt-koyanagi-harada-syndrome-presenting-with-sunset-glow-fundus-vitiligo-preserved-vision-and-incidental-ca-19-9-elevation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.98983","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}